Feature | February 27, 2013

Oncology Information Systems' Reporting and Alerts Leave Providers Wanting More

As meaningful use and ACOs pick up steam, oncology providers contend with regulatory pressures with or without help from their vendors

Oncology Information Management Systems KLAS Meaningful Use Reports Alert

February 27, 2013 — Alerts and reporting are two of the most challenging aspects of medical oncology, in addition to being the tools providers are least happy with overall. This is according to a new report from KLAS titled Oncology 2012: Pulling the Curtain Back.

Study findings reveal that oncology information system vendors struggle with alerts. Specifically, Epic, Varian and Elekta seem to perform below average. Reporting is also an area for improvement. Providers report that Varian and Elekta's canned reports are not robust enough to meet their needs, and the customized reports are difficult to use. Epic's customized reports are not as user friendly as providers would like them to be.

Meaningful use (MU) is another hot button for providers. The vast majority of oncology providers interviewed indicate that they are planning to attest for MU, but according to the report, vendors differ in their ability to partner with providers in that effort. Altos and BMSi are the best reported MU partners because they are more hands on and appear to be more focused on customer needs.

Though Varian is one of the dominant players in the oncology IT market, the report indicates that they are not the best MU partner. The MU version of Varian ARIA did not come out on the promised timeline, and some providers report that Varian seems out of touch with customers. Additionally, Epic is identified as a vendor that could improve due to the fact that the system is not designed for all the needs of oncology providers.

With MU Stage 2 bearing down, patient portals are also identified as an important consideration for oncology providers. Only 30 percent of those surveyed said they are currently using a patient portal, and many still need to make that decision.

"Most of the Epic and Altos customers in the study said they are using patient portals; however, we spoke with only a small number of those customers," said Monique Rasband, oncology research director and author of the report. "The majority of Elekta and Varian customers have not yet adopted a portal. Most Varian and Elekta customers said they are looking to their current oncology IT vendor to supply a portal, in spite of most portals being rudimentary at this point."

This study includes ratings on medical and radiation oncology IS vendors. Vendors rated in radiation oncology are BMSi, Elekta and Varian. Vendors rated in medical oncology are Altos (early data), Elekta, Epic, IntrinsiQ and Varian. To learn more about the oncology IS market and the vendors in this study, providers and vendors can review the full report Oncology IT: Pulling the Curtain Back. This report is available to healthcare providers at a significant discount.

For more information: www.KLASresearch.com/KLASreports

Related Content

RAD Technology, modular cancer treatment facilities, radiation vaults, U.S. patent
News | Radiation Therapy | February 04, 2016
RAD Technology Medical Systems (RAD) has added a new patent to its expanding portfolio of modular building technologies...
ACR 2016, American College of Radiology, Informatics and Innovations sessions, healthcare IT
News | Information Technology | February 04, 2016
The American College of Radiology’s ACR 2016 annual meeting offers sessions on advanced data science tools, clinical...
University of Maryland School of Medicine, UM SOM, Maryland Proton Alliance, MPA, proton therapy
News | Proton Therapy | February 04, 2016
The University of Maryland School of Medicine (UM SOM) announced the establishment of the Maryland Proton Alliance (MPA...

The Carestream Vue Reporting module can help generate detailed diagnostic reports.

Feature | Enterprise Imaging | February 03, 2016 | Jeff Zagoudis
The U.S. healthcare system’s ongoing transformation from a volume-based payment model to a value-based one is being...
Stanford Health Care, MyHealth mobile app, Android
News | Patient Engagement | February 03, 2016
Stanford Health Care recently released a new app that allows patients using Android smartphones to easily access their...
MEDraysintell, nuclear medicine, proton therapy, brachytherapy, global markets, 2030
News | Radiation Therapy | February 03, 2016
The nuclear medicine, proton therapy and brachytherapy markets represent less than 0.1 percent of global health...

Accuray’s Delivery Analysis tracks patient procedures and compares trends across patient populations.

Feature | Radiation Oncology | February 03, 2016 | By Rachael Bennett, R.T.(R)(T)
The American Society for Radiation Oncology (ASTRO) annual meeting held last October drew a crowd of more than 11,000...

The MRIdian from Viewray is a hybrid MRI-guided radiotherapy system. Elekta and Philips are currently working on a joint venture, which they hope to launch in 2018.

Feature | Radiation Oncology | February 03, 2016 | Jeff Zagoudis
Computed tomography (CT) has long been the gold standard for image acquisition during radiation therapy treatment...

Image courtesy of Philips Healthcare

Feature | Clinical Decision Support | February 03, 2016 | Dave Fornell
Healthcare providers will need to start preparing for the next big healthcare information technology (IT) implementat
DCIS, ductal carcinoma in situ, radiation therapy, survival benefit, Brigham and Women's Hospital study
News | Women's Health | February 02, 2016
Investigators from Brigham and Women's Hospital (BWH) and the Dana-Farber Cancer Institute have found that a set of...
Overlay Init